Palantir Technologies Inc. - Class A Common Stock (PLTR)
179.53
+6.46 (3.73%)
NASDAQ · Last Trade: Oct 7th, 1:56 AM EDT
Detailed Quote
Previous Close
173.07
Open
179.18
Bid
179.30
Ask
179.43
Day's Range
177.83 - 182.95
52 Week Range
63.40 - 190.00
Volume
52,504,269
Market Cap
363.99B
PE Ratio (TTM)
598.43
EPS (TTM)
0.3
Dividend & Yield
N/A (N/A)
1 Month Average Volume
56,835,313
Chart
About Palantir Technologies Inc. - Class A Common Stock (PLTR)
Palantir Technologies is a public software company that specializes in big data analytics and provides platforms for organizations to integrate, visualize, and analyze large amounts of data from disparate sources. Its flagship products, Palantir Gotham and Palantir Foundry, are designed to assist government agencies and commercial enterprises in making data-driven decisions by offering advanced analytical capabilities, collaborative tools, and visualization features. The company has gained prominence for its work with intelligence and defense organizations, as well as its growing presence in various industries such as finance, healthcare, and manufacturing, enabling clients to derive actionable insights and enhance their operational efficiency. Read More
1. Introduction As of September 29, 2025, Palantir Technologies Inc. (NASDAQ: PLTR) stands as a pivotal force in the realm of big data analytics, integration, and artificial intelligence (AI). Founded in 2003 with a mission to develop software for counter-terrorism, the Denver, Colorado-headquartered company has evolved into a global provider of sophisticated platforms for both [...]
The United States is grappling with a significant economic data blackout, as a recent government shutdown has brought the release of crucial unemployment figures from the Bureau of Labor Statistics (BLS) to a grinding halt. This unprecedented situation has left economists, policymakers, and investors without a definitive pulse on the
As the financial markets navigate the latter half of 2025, a significant trend is emerging from the individual investor landscape: a robust surge in retail trading activity. While specific official data for the Schwab Trading Activity Index (STAX) for September 2025 is still pending release, strong underlying trends and historical
Wall Street's leading strategists are painting an increasingly optimistic picture for the financial markets, with a notable trend of raised S&P 500 targets for late 2025 and into 2026. This burgeoning confidence is overwhelmingly fueled by the transformative potential of artificial intelligence (AI) and a robust outlook for the
The U.S. stock market is currently experiencing a remarkable surge, with major indices hovering at or near all-time record highs as of early October 2025. This robust performance is predominantly fueled by an insatiable investor appetite for artificial intelligence (AI) innovation and the widespread anticipation of further interest rate
On October 6, 2025, a landmark strategic partnership between Advanced Micro Devices (NASDAQ: AMD) and OpenAI sent shockwaves through the financial markets, propelling AMD's stock to unprecedented highs. This multibillion-dollar deal, aimed at significantly bolstering OpenAI's artificial intelligence infrastructure with AMD's cutting-edge AI chips, instantly repositioned AMD as a formidable
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Monday and uncover the stocks that are leading the way in terms of trading volume and market attention.
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top S&P500 gainers and losers in today's session.
The landscape of the global tech industry is undergoing a profound and rapid transformation, driven by the accelerating integration of Artificial Intelligence. Recent surveys and reports from 2024-2025 paint a clear picture: AI is not merely enhancing existing roles but is fundamentally redefining the tech workforce, leading to a significant wave of job reassignments and, [...]
Wall Street is currently experiencing an extraordinary bull run, with major indices shattering previous records as the financial markets surge into uncharted territory. This remarkable ascent, as of October 2025, is overwhelmingly powered by the technology sector, which continues to demonstrate robust growth and innovation. At the heart of this
The financial markets are currently experiencing a dynamic period, marked by significant movements across various sectors, driven by technological advancements, shifts in consumer behavior, and evolving macroeconomic conditions. As of early October 2025, a diverse group of public companies, from artificial intelligence pioneers to established financial institutions and consumer beverage
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses.
Palantir Technologies Inc. (NASDAQ: PLTR) has declined to participate in the U.K. government's digital ID scheme, citing concerns about public support and potential misuse.
DENVER and MINNEAPOLIS, Oct. 06, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) has selected Palantir Technologies (Nasdaq: PLTR) to transform the healthcare AI and Real-World Data (RWD) analytics marketplace. Palantir’s Artificial Intelligence Platform will provide the infrastructure for OneMedNet’s iRWD™ near real-time AI powered provider network (‘network’) enabling OneMedNet to empower life sciences, medical device, and research organizations with anonymized, regulatory-grade clinical data and advanced analytics to accelerate the development of cutting-edge medical solutions efficiently.
OneMedNet Corporation (Nasdaq: ONMD) has selected Palantir Technologies (Nasdaq: PLTR) to transform the healthcare AI and Real-World Data (RWD) analytics marketplace. Palantir’s Artificial Intelligence Platform will provide the infrastructure for OneMedNet’s iRWD™ near real-time AI powered provider network (“network”) enabling OneMedNet to empower life sciences, medical device, and research organizations with anonymized, regulatory-grade clinical data and advanced analytics to accelerate the development of cutting-edge medical solutions efficiently.
